Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity

BACKGROUND: We conducted a retrospective review of the dose, toxicity, and efficacy of second line gemcitabine plus nab-paclitaxel (G + Nab-P) after FOLFIRINOX in patients with metastatic and locally advanced unresectable pancreatic cancer. METHODS: In this retrospective study, we included all patie...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Exp Hematol Oncol
Main Authors: Zhang, Yue, Hochster, Howard, Stein, Stacey, Lacy, Jill
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2015
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4597390/
https://ncbi.nlm.nih.gov/pubmed/26451276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0025-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker